All Eyes on Antibiotics?
When you think about counterfeit and falsified medicines in developing countries, antimalarials are likely to spring to mind first – but we shouldn’t forget that antibiotics are also important targets for fraudsters. In either case, more quality control testing is needed.
Harparkash Kaur |
As scientists and medicine makers, we all know how crucial antibiotics are; indeed, sulfonamides and beta-lactam antibiotics have saved countless lives since their discovery in the 1930s. However, economic and regulatory challenges have led to disengagement from antibiotic research; though countless numbers of generic antibiotics are being manufactured globally, the number of large multinational pharmaceutical companies actively engaged in antibiotic research has fallen from 18 in 1990 to just four in 2011 – AstraZeneca, Novartis, GlaxoSmithKline and Sanofi-Aventis.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine